- Home
- AUUD vs MTNB Comparison
AUUD vs MTNB Comparison
Compare AUUD & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- MTNB
- Stock Information
- Founded
- AUUD 2012
- MTNB 2013
- Country
- AUUD United States
- MTNB United States
- Employees
- AUUD N/A
- MTNB N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- MTNB Health Care
- Exchange
- AUUD Nasdaq
- MTNB Nasdaq
- Market Cap
- AUUD 2.9M
- MTNB 3.1M
- IPO Year
- AUUD 2021
- MTNB N/A
- Fundamental
- Price
- AUUD $4.32
- MTNB $0.56
- Analyst Decision
- AUUD
- MTNB Hold
- Analyst Count
- AUUD 0
- MTNB 1
- Target Price
- AUUD N/A
- MTNB N/A
- AVG Volume (30 Days)
- AUUD 36.7K
- MTNB 29.1K
- Earning Date
- AUUD 03-05-2025
- MTNB 05-08-2025
- Dividend Yield
- AUUD N/A
- MTNB N/A
- EPS Growth
- AUUD N/A
- MTNB N/A
- EPS
- AUUD N/A
- MTNB N/A
- Revenue
- AUUD N/A
- MTNB N/A
- Revenue This Year
- AUUD N/A
- MTNB N/A
- Revenue Next Year
- AUUD N/A
- MTNB N/A
- P/E Ratio
- AUUD N/A
- MTNB N/A
- Revenue Growth
- AUUD N/A
- MTNB N/A
- 52 Week Low
- AUUD $3.35
- MTNB $0.48
- 52 Week High
- AUUD $96.90
- MTNB $18.10
- Technical
- Relative Strength Index (RSI)
- AUUD 40.49
- MTNB 48.95
- Support Level
- AUUD $3.35
- MTNB $0.52
- Resistance Level
- AUUD $6.19
- MTNB $0.58
- Average True Range (ATR)
- AUUD 0.57
- MTNB 0.05
- MACD
- AUUD -0.04
- MTNB 0.00
- Stochastic Oscillator
- AUUD 34.18
- MTNB 48.50
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.